Feasibility of Treating Post-Transplant Minimal Residual Disease in Children with Acute Leukemia

Outcomes for patients with hematologic malignancies who experience overt relapse after allogeneic hematopoietic stem cell transplantation (HCT) are poor. There are limited data on outcomes of post-transplant minimal residual disease (MRD). In this single institution, retrospective cohort analysis of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shah, Nirali N., Borowitz, Michael J., Robey, Nancy C., Gamper, Christopher J., Symons, Heather J., Loeb, David M., Wayne, Alan S., Chen, Allen R.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4077899/
https://ncbi.nlm.nih.gov/pubmed/24680975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.03.021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars